Dw. Silversides et al., EFFECTS OF SHORT-TERM EXPOSURE TO HYDROXYFLUTAMIDE IN-UTERO ON THE DEVELOPMENT OF THE REPRODUCTIVE-TRACT IN MALE-MICE, Canadian journal of physiology and pharmacology, 73(11), 1995, pp. 1582-1588
To determine if and when short-term ablation of androgen action compro
mises the development of the male reproductive tract in mice, the andr
ogen receptor antagonist hydroxyflutamide was administered orally to p
regnant FVB/N mice and the reproductive tracts of the male offspring w
ere examined when adult. Hydroxyflutamide (30 mg per day) for 5 days f
rom day 11 to day 15 of gestation caused hypospadias in all male proge
ny. However, testis weights, seminal vesicle weights, and serum testos
terone levels were not affected (p > 0.05) but caput-corpus epididymal
weights were 15% lower than controls (p < 0.02). Shorter periods of t
reatment that included day 14 or 15 caused hypospadias, but treatments
that did not include days 14 and 15 did not (p < 0.002). Hydroxyfluta
mide (30 mg, once or twice daily for 2 consecutive days) between days
15 and 20 of gestation demonstrated that androgen ablation on days 15
& 16 caused hypospadias, absence of prostate, and scrotal location of
the seminal vesicles with abdominal testes (p < 0.05). Males exposed l
ater in pregnancy had prostates, but the weights were reduced (p < 0.0
01); testes were scrotal and seminal vesicles were abdominal; caput-co
rpus epididymal weights were 15-30% lower than controls (p < 0.05), bu
t the tubule contained large numbers of spermatozoa. Furthermore, test
is weights, serum testosterone, and the response of the testis to a hu
man chorionic gonadotropin (hCG) challenge in vitro were not compromis
ed by hydroxyflutamide, and seminiferous tubules exhibited normal sper
matogenesis. When males that had been exposed to hydroxyflutamide on d
ays 13 & 14, 15 & 16, 17 & 18, and 19 & 20 were housed with sexually m
ature females, pregnancies resulted only from the day 19 & 20 treatmen
t group. Thus, there are long-term effects caused by short-term blocka
de of androgen action at critical times during pregnancy and such effe
cts could result in the inability to impregnate, irrespective of any e
xternally visible indications of developmental anomalies.